[Duration and intensity of the effect of intravenously and perorally administered as well as inhaled orciprenaline on the flow resistance of the respiratory tract in obstructive respiratory tract diseases].
D000336:Aerosols; D000368:Aged; D001783:Blood Flow Velocity; D001991:Bronchitis / Q000188:drug therapy*; D002200:Capillary Resistance / Q000187:drug effects*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D009921:Metaproterenol / Q000008:administration & dosage; D008875:Middle Aged; D010919:Placebos; D010991:Plethysmography; D012118:Resorcinols / Q000008:administration & dosage*; D012138:Respiratory Therapy
D000336:Aerosols; D010919:Placebos; D012118:Resorcinols; D009921:Metaproterenol
Dauer und Starke der Wirkung von intravenos aund peroral verabreichtem sowie inhaliertem Orciprenalian auf den Strömunswiderstand der Atemwege bei obstruktiven Atemwegserkrankungen.